ArticleEBioMedicine2022

Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern.

Branislav Kovacech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.